Long-Term Investing: Hot Or Not? The headlines blaze

New Post Public Reply Private Reply Replies (0) Message Board
NITE

Long-Term Investing: Hot Or Not?
The headlines blaze from magazine titles, book covers, newspapers and websites: "Beat the market!", "Here's the strategy you need!", "Get rich trading!" and "A five-star fund!" The talking heads on television fuel the fire even further, with some of them dancing around like crazed animals, frothing at the mouth and screaming for investors to "Buy!" It's enough to sway the convictions of even the most rational investors. Unfortunately, these seductive siren songs usually turn out to be all wrong. If you've ever struggled to keep up with market fluctuations in your investment strategy, read on to learn more about a simple investment strategy that will keep your returns on the rise.

The Truth
If these masterful investment strategies were as good as their advertisements, wouldn't there be a lot more rich people in your neighborhood? If the strategies can't lose, why do the mutual fund firms, wire houses and discount brokerages book huge profits while the average investor fares worse than an unmanaged index? The answer is simple: the financial services firms are paid even if you lose money.

The Numbers Don't Lie
According to Quantitative Analysis of Investor Behavior (April 2012), a study by the financial research organization Dalbar, the average equity investor a 3.49% total yearly return for the 20-year period. The S&P 500 index earned an annual return of 7.81%. The index didn't just beat the investors - it crushed them!

Dalbar reports that the average equity mutual fund investor purchased a fund and held it for just 3.29 years before selling. That was during good times - the holding period slipped to just 2.5 years during bear markets. Retention rates peaked in 2004 to 2007 above four years. However, the 2008 financial crisis saw these rates drop down a little above three years. Each time period suggests that the average mutual fund investor understands the objective of long-term investing or the risks involved in short-term trading in pursuit of performance.

The concept of selling the fund you have in order to purchase something different is encouraged by the idea that better returns can be had if only you choose "the right fund." In seeking the most desirable of all investments, most investors turn to historical performance as their guide. They see a fund with a "five-star" rating or a particular sector of the economy (such as technology) delivering a "hot" performance, and they trade in their current investments to purchase what they are sure must be "the next big thing." It's a classic mistake.

By the time the average investor is aware of a top-performing fund or industry sector, they are looking at last year's winner. The gains have happened already. The folks that made big money did it last year, last quarter or even last week. It doesn't take long before the investment is overpriced, overvalued and headed downhill. It's the perfect time to sell, but generally a foolish time to buy. Unfortunately, as the Dalbar numbers demonstrate, it's precisely the time that far too many investors send their dollars in the wrong direction, buying an investment that is unlikely to repeat its past performance anytime soon.
Even when a few lucky investors do manage to grab on to the tail end of a trend, the strategy of chasing performance usually ends badly. For the most part, these investors are too greedy to sell and lock in their profits. They hold the investment as long as the price is going up and continue to hold it on the way back down - and, when the house of cards folds, they can get hurt.

Doesn't Anybody Win?
There's absolutely no doubt that some investment managers beat their benchmarks. Some even manage the task for prolonged periods of time. That said, even Warren Buffet has down years. It is simply unrealistic to expect that any investment or any strategy will always deliver positive performance.

With that in mind, it is equally important to remember that a bad year does not reflect a bad strategy necessarily. Market conditions change all the time. Factors beyond an individual company's control, such as bad weather, political problems, war, terrorism or simply the need to remodel aging facilities, can cause temporary setbacks. In the long term, these setbacks are just blips on the radar - not a reason to abandon a successful investment.

The Long-Term Trend Is Your Friend
Short-term market performance is unpredictable. Daily price swings occur, sometimes for seemingly irrational reasons, which is why long-term investors ignore short-term distractions. To get a better sense of the long term, look at the performance of any major market index over a 20-year period. The trend is for the numbers to move upward. Sure, there are peaks and valleys, but overall, the direction of the movement is up.

Plan to Win
Take advantage of the long-term trend when planning your investment strategy. Accept the fact that your portfolio won't always be in the "right" place at the "right" time, and that you won't always own the "hot" investment. Instead of acting like an amateur and chasing short-term performance, plan your investments like a professional.

Set a long-term goal and then choose a strategy that has a high likelihood of achieving that goal. Make logical decisions, not emotional reactions. Think about inflation and don't count on cash to appreciate at a greater rate. Rely on the time-tested theories of diversification and low-cost investing to help you over the long term.
The Bottom Line
Although many people manage to build sizable amounts of wealth by jumping from one "hot" strategy to another, the odds are against you if you try to follow in their footsteps. One wrong move and your portfolio's value could suffer irreversible damage. In the long-run, buying and holding will probably leave you at least as well-off, if not better, and it sure is a lot less stressful!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tampa General's Food Bet Earns a 2026 Innovation Award

Updated Category News Views 102

Hospital meals have long been the punchline nobody bothered to fix, which is why Tampa General Hospital's latest recognition deserves a closer look. The not-for-profit academic health system was named the 2026 Inno Pick by the Tampa Bay Business Journal for its Food as Medicine initiative, its fifth straight year landing among the publication's Inno Award honorees. Awards...

Continue Reading
Mars Sets $2 Billion Debt Tender With Kellanova Notes

Updated Category News Views 124

A two-billion-dollar vacuum cleaner just switched on inside Mars’s debt stack, and the timing is anything but casual. On November 20, Mars fixed the pricing for cash tender offers spanning selected Mars and Kellanova senior notes, with holders facing a 5:00 p.m. New York deadline that same day. This is the kind of filing that looks like bond-market plumbing until you...

Continue Reading
Chord's $550 Million Exit Tightens Its Basin Focus

Updated Category News Views 76

One map pin just disappeared from Chord Energy’s corporate wall, and that matters more than the usual deal-closing confetti. Chord has completed the sale of its entire non-operated Marcellus position to POSCO International for $550 million in gross consideration. For shareholders in NASDAQ:CHRD, this is not a flashy new drilling story. It is a cleanup job, and sometimes...

Continue Reading
Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 116

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading
Dallas College Recognition Signals Workforce Value

Updated Category News Views 63

Economic mobility rarely arrives with brass bands, but it can show up in a community-college ranking. Dallas College has landed on TIME and Statista's inaugural America’s Best Community Colleges 2027 list, one of 250 schools selected from roughly 1,100 nationwide. For a region that keeps talking about talent pipelines, this is a useful piece of outside validation—not...

Continue Reading
Oatly’s $4.13 Tender Offer Is a Legal Detour, Not a Sale

Updated Category News Views 122

A $4.13 cash offer trading against a $7.17 close is the sort of thing that makes investors squint hard, and Verlinvest is practically waving a flag telling them why. This is not a conventional attempt to buy Oatly Group AB. It is a technical tender offer built to satisfy Swedish takeover rules while Verlinvest buys out its joint-venture partner’s interest in Oatly’s...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 72

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
KONST Pitches Asia GPU Uptime as AI Demand Gets Real

Updated Category News Views 131

GPU racks are easy to admire when the lights are on; keeping them useful at 3 a.m. is where the bruises show. KONST arrived at SC26 in Chicago with a sensible pitch for an AI-infrastructure market that is getting less impressed by shiny hardware lists and more obsessed with whether the thing actually works. Its theme, “24/7 GPUs Delivered in Asia,” puts the emphasis...

Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Page Library Grant Makes a Practical Case for Access

Updated Category News Views 56

A library card is not much use if a family cannot reach the help behind it. That plain reality sits at the center of AZ Blue Health Choice’s $10,000 contribution to the Page Public Library Family Resource Center, announced November 20, 2026. This is a modest dollar figure in the grand scheme of health care, but it is aimed at the kind of everyday gaps that can become...

Continue Reading

Top 5 Most Recently Viewed Articles

Seasonal Hiring Booms as Firms Eye Long-Term Talent

Updated Category News Views 327

A Strategic Shift in Seasonal Hiring It ain't just about the holiday rush anymore, folks. Companies are waking up to the idea that seasonal gigs are more than a temporary Band-Aid. This year, nearly 2 out of 5 companies are planning to bring more seasonal folks into the fold compared to last year. That means a good dose of them are looking for longer-term value—like...

Continue Reading
Nebius Secures $700 Million to Accelerate AI Infrastructure Growth

Updated Category News Views 269

Nebius Secures $700 Million to Accelerate AI Infrastructure Growth Nebius Group N.V. (“Nebius Group”, “Nebius” or the “Company”; NASDAQ:NBIS), a prominent player in AI infrastructure, has made an exciting announcement regarding a substantial private placement financing. In a strategic move to bolster its operations, the company has secured USD 700 million from...

Continue Reading
Xenon Pharmaceuticals Welcomes Tucker Kelly as CFO

Updated Category News Views 183

Xenon Pharmaceuticals Welcomes Tucker Kelly as CFO Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a biopharmaceutical company specializing in neuroscience, has made a significant move by appointing Tucker Kelly as the new Chief Financial Officer (CFO). This decision signals the company's commitment to strategic financial management as it gears up for the commercialization of...

Continue Reading
Brookfield Makes Big Moves in Japan's Real Estate Market

Updated Category News Views 302

Brookfield's Bold Ventures into Japan's Real Estate Landscape Canadian investment firm Brookfield Asset Management (TSX: BAM) has recently made headlines with its significant real estate endeavors in Japan, closing two major deals that amount to a staggering $1.6 billion. The Significant Investments Overview The recent acquisitions involve a noteworthy stake in the iconic...

Continue Reading
Pacira BioSciences Facing Legal Challenges and Investor Updates

Updated Category News Views 170

Legal Proceedings Impacting Pacira BioSciences, Inc. Shareholders of Pacira BioSciences, Inc. should be aware of a significant class action lawsuit that is currently unfolding. This lawsuit, noted for its complexity, aims to address allegations of securities fraud impacting investors. The firm representing the investors, is Levi & Korsinsky, a well-established legal group...

Continue Reading